One type of stock that didn't see huge losses today: Weight loss drug makersByBruce GilPublishedAugust 5, 2024
Zepbound is back on the shelves — but shortage isn't over yet, FDA saysByBruce GilPublishedAugust 5, 2024
The struggling DNA testing company 23andMe is not going private — yetByBruce GilPublishedAugust 2, 2024
Google has pulled its Olympics-themed AI ad that gave viewers the ickByBruce GilPublishedAugust 2, 2024
ESPN's and Warner Bros. Discovery's joint live sports streaming service finally has a priceByBruce GilPublishedAugust 1, 2024
Now playing Zepbound, the weight loss drug from Eli Lilly, found to help cut heart failure risksPublishedAugust 1, 2024
Now playing Eli Lilly's weight loss drug Zepbound could cut heart failure risks, trial findsByBruce GilPublishedAugust 1, 2024
Boar's Head recalls 7 million more pounds of deli meat over listeria outbreakByBruce GilPublishedJuly 31, 2024
People are overdosing on cheaper, off-brand versions of Ozempic, FDA warnsByBruce GilPublishedJuly 30, 2024
